Viewing Study NCT04394650


Ignite Creation Date: 2025-12-24 @ 4:54 PM
Ignite Modification Date: 2025-12-29 @ 9:32 AM
Study NCT ID: NCT04394650
Status: COMPLETED
Last Update Posted: 2024-07-26
First Post: 2020-05-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of CC-98633, BCMA-targeted Chimeric Antigen Receptor (CAR) T Cells, in Participants With Relapsed and/or Refractory Multiple Myeloma
Sponsor: Juno Therapeutics, a Subsidiary of Celgene
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module